Skip to main content

Table 1 Neurophysiological and Magnetic Resonance Spectroscopy findings at baseline and follow-up visits

From: Cerebellar ataxia and sensory ganglionopathy associated with light-chain myeloma

Neurological dysfunction in coeliac disease and

Neurological dysfunction in coeliac disease and

Neurological dysfunction in coeliac disease and

Neurological dysfunction in coeliac disease and

Neurological dysfunction in coeliac disease and

Neurological dysfunction in coeliac disease and

Neurological dysfunction in coeliac disease and

Neurological dysfunction in coeliac disease and

Neurological dysfunction in coeliac disease and

Neurological dysfunction in coeliac disease and

Neurological dysfunction in coeliac disease and

Neurological dysfunction in coeliac disease and

Neurological dysfunction in coeliac disease and

Neurological dysfunction in coeliac disease and

Baseline

11.7

8.8

6.3

X

0.8

0.8

2.9

0.7/0.7

10.6/16.3

60.5/55.3

60.7/55.5

0.95

1.04

F/U at 30 m

10.4

X

4.4

11.1

NR

0.5

NR

NR

X

X

X

0.83

1.17

F/U at 42 m

10.7

6.6

3.5

11.1

NR

NR

NR

NR

X

X

X

0.80

0.95

F/U at 54 m

X

X

X

X

X

X

X

X

X

X

X

0.79

0.80

  1. CMAP; compound muscle action potential, SNAP; sensory nerve action potential, L; Left, R; Right, NR; no response, X; not done
  2. Median and ulnar studies - orthodromic, radial, peroneal and sural - antidromic
  3. cR2 = contralateral R2; iR2 = ipsilateral R2